News GlaxoSmithKline plc Liquidnet

Stocks

GSK

GB0009252882

Pharmaceuticals

Delayed Liquidnet			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

10-02	Major drugmakers turn to China for licensing deals	RE
10-01	GSK plc : JP Morgan reiterates its Sell rating	ZD

All News

Mentions Relevance

10-01	GSK plc : JP Morgan reiterates its Sell rating	ZD
09-30	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	MT
09-30	Wave Life Sciences, Inc. Announces GSK?s Selection Of siRNA Program To Transition To GSK For Further Development	CI
09-29	GSK plc : Gets a Neutral rating from Deutsche Bank	ZD
09-29	GSK plc : Jefferies keeps its Buy rating	ZD
09-28	Hutchmed begins phase Ia trial of HMPL-A830 in China	AN
09-28	Hutchmed Begins Phase Ia Clinical Trial of KRAS-EGFR Antibody Conjugate Cancer Therapy	MT
09-24	GSK plc Presents at Bernstein Insights: Healthcare Leaders and Disruptors ? 3rd Annual Healthcare Forum, Sep-23-2026 03:50 PM
09-23	GSK plc Presents at Bank of America Global Healthcare Conference 2026, Sep-23-2026 08:15 AM
09-18	European Equities Traded in the US as American Depositary Receipts Drop in Friday Trading	MT
09-18	GSK plc : Deutsche Bank remains Neutral	ZD
09-17	ViiV Healthcare Partners with Prevention Access Campaign (PAC) to Celebrate 10 Years of U=U and Look to The Future	BU
09-17	GSK plc : UBS is Neutral	ZD
09-16	AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down	MT
09-15	GSK plc Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 01:05 PM
09-15	GSK plc: Priced for the storm, being built for thereafter
09-15	GSK Upgraded to Buy as Berenberg Notes Pipeline Momentum; Price Target Raised	MT
09-15	Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.	BU
09-15	Berenberg Upgrades GSK to Buy, Raises PT	MT
09-15	GSK to Acquire Experimental Blood Cancer Therapy From Chimagen in $750 Million Deal	MT
09-15	Berenberg Upgrades GSK to Buy From Hold, Raises Price Target to $60 From $54	MT
09-15	Berenberg likes GSK; Deutsche Bank lifts Astra	AN
09-15	GSK agrees up to USD750 million deal for blood cancer-targeting drug	AN
09-15	GSK plc : Deutsche Bank remains Neutral	ZD
09-15	GSK Agrees to Buy Potential Blood Cancer Treatment for Up to $750 Million	MT